HAART-mediated Immune Restoration in Chronic Obstructive Pulmonary Disease

HAART 介导的慢性阻塞性肺疾病的免疫恢复

基本信息

项目摘要

DESCRIPTION (provided by applicant): Highly active antiretroviral therapy (HAART) has been linked to increased risk of chronic medical conditions, from cardiovascular complications to autoimmune diseases. We have recently found that use of HAART is independently associated with worse airway obstruction. The overall goal of this project is to investigate the hypothesis that immune restoration through HAART leads to increased airway obstruction/chronic obstructive pulmonary disease via propagation of a chronic inflammatory response to pulmonary pathogens and/or autoantigens. We will study the effects of HAART initiation through a prospective longitudinal study of HIV outpatients at the University of Pittsburgh, as well as through an analysis of specimens archived as part of the Multicenter AIDS Cohort Study and the Women's Interagency Study. Research Aims: (1) To test the hypothesis that HAART initiation is associated with increased airway obstruction and/or emphysema. (2) To test the hypothesis that initiating HAART induces a "modified immune restoration syndrome," creating a pro-inflammatory environment in response to an underlying pathogen and/or through unmasking of autoantigens. (3) To test the hypothesis that development of a chronic inflammatory response, either in response to Pneumocystis or autoantigens, is associated with increased airway obstruction and/or emphysema. Career Goals: This research proposal presents a comprehensive plan by which the P.I. will help determine pathophysiologic mechanisms connecting HAART and COPD and will also achieve the following: 1. Broaden the candidate's ability to perform clinical/translational studies through the experience of conducting a prospective longitudinal study; 2. Increase the candidate's analytical techniques in statistical analysis and modeling; and 3. Transform the candidate into a leading independent investigator in HIV-associated pulmonary disease through intensive didactics, conferences, and research experience. ! PUBLIC HEALTH RELEVANCE: This proposal represents a major step in determining the impact of HAART and immune restoration on the development of COPD and will provide a crucial foundation for future studies of HIV-related chronic lung disease. Given the increasing numbers of aging HIV-infected subjects with prolonged exposure to HIV and HAART, this study will provide important information for care and treatment of these patients.
描述(由申请人提供):高度活跃的抗逆转录病毒疗法(HAART)与慢性病风险增加有关,从心血管并发症到自身免疫性疾病。我们最近发现,HAART的使用与较差的气道阻塞独立相关。该项目的总体目的是研究以下假设:通过HAART通过HAART进行免疫恢复会导致气道阻塞/慢性阻塞性肺部疾病通过传播对肺部病原体和/或自身抗原的慢性炎症反应。我们将通过对匹兹堡大学的HIV门诊患者的前瞻性纵向研究来研究HAART启动的影响,以及通过对作为多中心AIDS同类研究的一部分进行存档的标本和妇女妇女跨性别研究的分析。研究目的:(1)测试HAART启动与气道阻塞和/或肺气肿有关的假设。 (2)测试启动HAART诱导“修饰的免疫恢复综合征”的假设,从而响应潜在的病原体和/或通过揭露自身抗原的膜,从而创造了促炎环境。 (3)测试以下假设:响应肺炎藻或自身抗原的慢性炎症反应的发展与气道阻塞和/或肺气肿的增加有关。职业目标:这项研究提案提出了一项全面的计划。将有助于确定连接HAART和COPD的病理生理机制,还将实现以下方面:1。通过进行前瞻性纵向研究的经验,扩大了候选人进行临床/翻译研究的能力; 2。在统计分析和建模中增加候选人的分析技术;和3。通过密集的教学,会议和研究经验,将候选人转变为与HIV相关肺部疾病的领先独立研究者。呢 公共卫生相关性:该提案代表了确定HAART和免疫恢复对COPD发展的影响的重要一步,并将为未来与HIV有关HIV相关慢性肺部疾病的研究提供至关重要的基础。鉴于越来越多的艾滋病毒感染受试者接触了HIV和HAART,这项研究将为这些患者的护理和治疗提供重要信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARJORIE Patricia GEORGE其他文献

MARJORIE Patricia GEORGE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARJORIE Patricia GEORGE', 18)}}的其他基金

2019 Aspen Lung Conference: Exploring new therapeutic pathways in pulmonary hypertension: metabolism, proliferation, and personalized medicine
2019阿斯彭肺会议:探索肺动脉高压的新治疗途径:代谢、增殖和个性化医疗
  • 批准号:
    9763199
  • 财政年份:
    2019
  • 资助金额:
    $ 13.11万
  • 项目类别:
HAART-mediated Immune Restoration in Chronic Obstructive Pulmonary Disease
HAART 介导的慢性阻塞性肺疾病的免疫恢复
  • 批准号:
    8403968
  • 财政年份:
    2011
  • 资助金额:
    $ 13.11万
  • 项目类别:
HAART-mediated Immune Restoration in Chronic Obstructive Pulmonary Disease
HAART 介导的慢性阻塞性肺疾病的免疫恢复
  • 批准号:
    8213455
  • 财政年份:
    2011
  • 资助金额:
    $ 13.11万
  • 项目类别:
HAART-mediated Immune Restoration in Chronic Obstructive Pulmonary Disease
HAART 介导的慢性阻塞性肺疾病的免疫恢复
  • 批准号:
    8786590
  • 财政年份:
    2011
  • 资助金额:
    $ 13.11万
  • 项目类别:
HAART-mediated Immune Restoration in Chronic Obstructive Pulmonary Disease
HAART 介导的慢性阻塞性肺疾病的免疫恢复
  • 批准号:
    8070207
  • 财政年份:
    2011
  • 资助金额:
    $ 13.11万
  • 项目类别:

相似国自然基金

TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
  • 批准号:
    82220108016
  • 批准年份:
    2022
  • 资助金额:
    252 万元
  • 项目类别:
    国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81800806
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
  • 批准号:
    81700824
  • 批准年份:
    2017
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
  • 批准号:
    81670269
  • 批准年份:
    2016
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
  • 批准号:
    31470998
  • 批准年份:
    2014
  • 资助金额:
    87.0 万元
  • 项目类别:
    面上项目

相似海外基金

Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
  • 批准号:
    10762280
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
  • 项目类别:
Multi-Omics Predictors of Oral HPV Outcomes among PLWH
PLWH 口腔 HPV 结果的多组学预测
  • 批准号:
    10557585
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
  • 项目类别:
Optimizing Treatment of Prostate Cancer in Men living with HIV
优化男性艾滋病毒感染者前列腺癌的治疗
  • 批准号:
    10771784
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
  • 项目类别:
Improving Healthcare Quality and Equity For Older Adults with HIV Under Value-Based Care Models
在基于价值的护理模式下提高艾滋病毒感染者的医疗质量和公平性
  • 批准号:
    10762522
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
  • 项目类别:
KNUST Aging and HIV Outcomes
KNUST 老龄化和艾滋病毒结果
  • 批准号:
    10751613
  • 财政年份:
    2023
  • 资助金额:
    $ 13.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了